774 related articles for article (PubMed ID: 26170375)
1. Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
Söderberg D; Kurz T; Motamedi A; Hellmark T; Eriksson P; Segelmark M
Rheumatology (Oxford); 2015 Nov; 54(11):2085-94. PubMed ID: 26170375
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease.
Kambas K; Chrysanthopoulou A; Vassilopoulos D; Apostolidou E; Skendros P; Girod A; Arelaki S; Froudarakis M; Nakopoulou L; Giatromanolaki A; Sidiropoulos P; Koffa M; Boumpas DT; Ritis K; Mitroulis I
Ann Rheum Dis; 2014 Oct; 73(10):1854-63. PubMed ID: 23873874
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.
Söderberg D; Segelmark M
Front Immunol; 2016; 7():256. PubMed ID: 27446086
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.
Shida H; Hashimoto N; Kusunoki Y; Hattanda F; Ogawa Y; Hayashi T; Nakazawa D; Masuda S; Tomaru U; Ishizu A
BMC Nephrol; 2018 Jun; 19(1):145. PubMed ID: 29929470
[TBL] [Abstract][Full Text] [Related]
5. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.
Kraaij T; Kamerling SWA; van Dam LS; Bakker JA; Bajema IM; Page T; Brunini F; Pusey CD; Toes REM; Scherer HU; Rabelink TJ; van Kooten C; Teng YKO
Kidney Int; 2018 Jul; 94(1):139-149. PubMed ID: 29606398
[TBL] [Abstract][Full Text] [Related]
6. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
[TBL] [Abstract][Full Text] [Related]
7. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps.
Huang YM; Wang H; Wang C; Chen M; Zhao MH
Arthritis Rheumatol; 2015 Oct; 67(10):2780-90. PubMed ID: 26097236
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis.
Tang S; Zhang Y; Yin SW; Gao XJ; Shi WW; Wang Y; Huang X; Wang L; Zou LY; Zhao JH; Huang YJ; Shan LY; Gounni AS; Wu YZ; Zhang JB
Clin Exp Immunol; 2015 Jun; 180(3):408-18. PubMed ID: 25644394
[TBL] [Abstract][Full Text] [Related]
9. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Masuda S; Nonokawa M; Futamata E; Nishibata Y; Iwasaki S; Tsuji T; Hatanaka Y; Nakazawa D; Tanaka S; Tomaru U; Kawakami T; Atsumi T; Ishizu A
Am J Pathol; 2019 Apr; 189(4):839-846. PubMed ID: 30677396
[TBL] [Abstract][Full Text] [Related]
10. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
[TBL] [Abstract][Full Text] [Related]
11. Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wang H; Sha LL; Ma TT; Zhang LX; Chen M; Zhao MH
PLoS One; 2016; 11(2):e0148197. PubMed ID: 26840412
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
[TBL] [Abstract][Full Text] [Related]
13. Detection by flow cytometry of anti-neutrophil cytoplasmic antibodies in a novel approach based on neutrophil extracellular traps.
Roitsch S; Gößwein S; Neurath MF; Leppkes M
Autoimmunity; 2018 Sep; 51(6):288-296. PubMed ID: 30994385
[TBL] [Abstract][Full Text] [Related]
14. Autophagy is induced by anti-neutrophil cytoplasmic Abs and promotes neutrophil extracellular traps formation.
Sha LL; Wang H; Wang C; Peng HY; Chen M; Zhao MH
Innate Immun; 2016 Nov; 22(8):658-665. PubMed ID: 27670946
[TBL] [Abstract][Full Text] [Related]
15. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation.
Ma YH; Ma TT; Wang C; Wang H; Chang DY; Chen M; Zhao MH
Arthritis Res Ther; 2016 Jan; 18():2. PubMed ID: 26739852
[TBL] [Abstract][Full Text] [Related]
17. The net effect of ANCA on neutrophil extracellular trap formation.
Heeringa P; Rutgers A; Kallenberg CGM
Kidney Int; 2018 Jul; 94(1):14-16. PubMed ID: 29933842
[TBL] [Abstract][Full Text] [Related]
18. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
19. The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis.
Takeda S; Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Nishio S; Atsumi T
Front Immunol; 2019; 10():1334. PubMed ID: 31249574
[No Abstract] [Full Text] [Related]
20. Protective effect of astaxanthin on ANCA-associated vasculitis.
Sun RL; Shang JC; Han RH; Xing GQ
Int Immunopharmacol; 2024 May; 132():111928. PubMed ID: 38537540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
